fluorothyazinone
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Aug 10, 2017 (NCT03205462)
Timeline
Indications
Mechanism of action
- DNA topoisomerase 4 subunit BINHIBITOR
parE inhibitor
- DNA gyrase subunit AINHIBITOR
gyrA inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06815549 | Phase 3 | Feb 17, 2025 | Government of Russia |
| NCT06135350 | Phase 2 | Nov 30, 2023 | Government of Russia |
| NCT03205462 | Phase 1 | Aug 10, 2017 | Government of Russia |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 3 | 3 | 3 | 2017 |
1 organizations
Page 1 / 1